Measuring and Modeling Health Care Costs
Ana Aizcorbe, Colin Baker, Ernst R. Berndt, and David M. Cutler
Abstract
National statistical agencies keep good track of how medical care dollars are spent—how much is paid to hospitals, physicians’ offices, pharmaceutical companies, and the like. However, it has proven much more challenging to measure the productivity of those dollars. What is medical care doing for our health? Given the large size of the US health care sector—roughly $3 trillion annually—measuring medical care productivity is essential in understanding what we get for our medical care dollars and in evaluating productivity growth in the economy as a whole. The National Bureau of Economic Researc ... More
National statistical agencies keep good track of how medical care dollars are spent—how much is paid to hospitals, physicians’ offices, pharmaceutical companies, and the like. However, it has proven much more challenging to measure the productivity of those dollars. What is medical care doing for our health? Given the large size of the US health care sector—roughly $3 trillion annually—measuring medical care productivity is essential in understanding what we get for our medical care dollars and in evaluating productivity growth in the economy as a whole. The National Bureau of Economic Research/Conference on Research in Income and Wealth last published a volume devoted to medical care accounting in 2001 (Cutler and Berndt, eds., “Medical Care Output and Productivity”). That volume brought to the forefront issues of productivity assessment in medicine. In the past 15 years, much has happened in the US health sector and in the ability to evaluate medical care productivity. This present volume thus returns to these themes. We report on methodological issues in measuring health care costs and outcomes, describe analyses of populations and market segments, explore prescription pharmaceutical markets in detail, consider issues in industrial organization and market design, and conclude with chapters on the “benefit incidence” of US public spending on medical care and the relationship between medical R&D and health improvement.
Keywords:
health costs,
pharmaceuticals,
health outcomes,
market design
Bibliographic Information
Print publication date: 2018 |
Print ISBN-13: 9780226530857 |
Published to Chicago Scholarship Online: January 2019 |
DOI:10.7208/chicago/9780226530994.001.0001 |
Authors
Affiliations are at time of print publication.
Ana Aizcorbe, editor
Bureau of Economic Analysis
Colin Baker, editor
U.S. Department of Health and Human Services
Ernst R. Berndt, editor
MIT Sloan School of Management
David M. Cutler, editor
Harvard University
More
Less